Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C59H105N17O11 |
| Molecular Weight | 1228.5723 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 9 / 9 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC[C@@H](NC(=O)[C@@H](CCCC)NC(=O)[C@@H](CCCC)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCC)NC(=O)[C@@H](CCCC)NC(=O)[C@@H](CCCC)NC(=O)[C@H](N)CCCNC(N)=N)C(=O)NCC(=O)N[C@H](CC1=CC=C(O)C=C1)C(N)=O
InChI
InChIKey=SFGFYNXPJMOUHK-PKAFTLKUSA-N
InChI=1S/C59H105N17O11/c1-7-13-22-40(51(81)68-36-48(78)69-47(49(61)79)35-37-29-31-38(77)32-30-37)71-53(83)42(24-15-9-3)73-55(85)44(26-17-11-5)75-57(87)46(28-20-34-67-59(64)65)76-56(86)45(27-18-12-6)74-54(84)43(25-16-10-4)72-52(82)41(23-14-8-2)70-50(80)39(60)21-19-33-66-58(62)63/h29-32,39-47,77H,7-28,33-36,60H2,1-6H3,(H2,61,79)(H,68,81)(H,69,78)(H,70,80)(H,71,83)(H,72,82)(H,73,85)(H,74,84)(H,75,87)(H,76,86)(H4,62,63,66)(H4,64,65,67)/t39-,40-,41-,42-,43-,44-,45-,46-,47-/m1/s1
| Molecular Formula | C59H105N17O11 |
| Molecular Weight | 1228.5723 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 9 / 9 |
| E/Z Centers | 2 |
| Optical Activity | UNSPECIFIED |
Delmitide is the decapeptide with antiinflammatory activity. It is the first low molecular weight compound inhibiting TNF production at a translational level. Also, delmitide inhibits production of IFN-gamma, IL-12 and IL-2. It targets TRAF6/IRAK4/MyD88 complex and inhibits phosphorylation of SAPKs (p38 and JNK). Delmitide inhibits AP1 and NFkB activation. Delmitide was developed for the potential treatment of Crohn's disease and ulcerative colitis; phase II trials for both these indications commenced in October 2001. Phase I trial in chemotherapy-induced diarrhea and the gastrointestinal complications of HIV were also initiated. However, no recent development has been reported.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:07:20 UTC 2023
by
admin
on
Fri Dec 15 16:07:20 UTC 2023
|
| Record UNII |
5759XTJ706
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C574
Created by
admin on Fri Dec 15 16:07:20 UTC 2023 , Edited by admin on Fri Dec 15 16:07:20 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
8502
Created by
admin on Fri Dec 15 16:07:20 UTC 2023 , Edited by admin on Fri Dec 15 16:07:20 UTC 2023
|
PRIMARY | |||
|
5759XTJ706
Created by
admin on Fri Dec 15 16:07:20 UTC 2023 , Edited by admin on Fri Dec 15 16:07:20 UTC 2023
|
PRIMARY | |||
|
100000175221
Created by
admin on Fri Dec 15 16:07:20 UTC 2023 , Edited by admin on Fri Dec 15 16:07:20 UTC 2023
|
PRIMARY | |||
|
CHEMBL2108587
Created by
admin on Fri Dec 15 16:07:20 UTC 2023 , Edited by admin on Fri Dec 15 16:07:20 UTC 2023
|
PRIMARY | |||
|
287096-87-1
Created by
admin on Fri Dec 15 16:07:20 UTC 2023 , Edited by admin on Fri Dec 15 16:07:20 UTC 2023
|
PRIMARY | |||
|
C79822
Created by
admin on Fri Dec 15 16:07:20 UTC 2023 , Edited by admin on Fri Dec 15 16:07:20 UTC 2023
|
PRIMARY | |||
|
219021
Created by
admin on Fri Dec 15 16:07:20 UTC 2023 , Edited by admin on Fri Dec 15 16:07:20 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->INHIBITOR OF EXPRESSION |
|
||
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
||
|
TARGET->INHIBITOR OF EXPRESSION |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET->INHIBITOR OF EXPRESSION |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
